ROCKWELL MEDICAL INC (RMTI) Stock Earnings & Estimates
NASDAQ:RMTI - US7743743004 - Common Stock
1.71 USD
-0.09 (-5%)
1.91 USD
+0.2 (+11.7%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 72.81M 17.57% | 83.612M 14.84% | 101.489M 21.38% | 69.741M -31.28% | 77.403M 10.99% | 75.163M -2.89% | N/A | |
| EBITDA YoY % growth | -16.2M 45.40% | -5.226M 67.74% | 2.788M 153.35% | -2.883M -203.39% | -2.47M 14.30% | N/A | N/A | |
| EBIT YoY % growth | -16.78M 44.69% | -6.67M 60.25% | 608K 109.12% | -5.421M -991.58% | -4.032M 25.63% | -3.955M 1.91% | 12.75M 422.41% | |
| Operating Margin | -23.05% | -7.98% | 0.60% | -7.77% | -5.21% | -5.26% | N/A | |
| EPS YoY % growth | -2.00 29.58% | -0.40 80.00% | -0.02 94.75% | -0.18 -750.00% | -0.13 25.71% | -0.14 -7.69% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 -191.80% | -0.05 -129.50% | -0.04 -2.00% | -0.04 28.60% | -0.03 33.33% | -0.03 44.44% |
| Revenue Q2Q % growth | 16.566M -41.50% | 17.49M -29.09% | 18.715M -1.05% | 19.043M 18.49% | 19.49M 17.65% | 20.159M 15.26% |
| EBITDA Q2Q % growth | -640.56K -117.93% | -229.5K -113.82% | -382.5K 53.41% | -136.68K 44.66% | -134.64K 78.98% | -186.66K 18.67% |
| EBIT Q2Q % growth | -1.363M -170.39% | -1.294M -149.40% | -1.508M -10.85% | -1.185M 12.14% | -1.149M 15.72% | -1.182M 8.67% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.05 -655.56% | -0.05 | 0.00 | 1.96% |
| Q1 2025 Q2Q % growth | -0.04 33.33% | -0.05 | 0.01 | 21.57% |
| Q4 2024 Q2Q % growth | -0.02 60.00% | 0.02 | -0.04 | -198.04% |
| Q3 2024 Q2Q % growth | 0.05 171.43% | 0.01 | 0.04 | 390.20% |
| Q2 2024 Q2Q % growth | 0.01 105.00% | -0.04 | 0.04 | 125.21% |
| Q1 2024 Q2Q % growth | -0.06 40.00% | -0.04 | -0.02 | -47.06% |
| Q4 2023 Q2Q % growth | -0.05 75.00% | -0.07 | 0.02 | 29.97% |
| Q3 2023 Q2Q % growth | -0.07 82.50% | -0.11 | 0.04 | 34.64% |
| Q2 2023 Q2Q % growth | -0.18 67.86% | -0.12 | -0.06 | -47.06% |
| Q1 2023 Q2Q % growth | -0.10 88.10% | -0.17 | 0.07 | 40.58% |
| Q4 2022 Q2Q % growth | -0.20 -122.22% | -0.40 | 0.20 | 49.72% |
| Q3 2022 Q2Q % growth | -0.40 54.55% | -0.49 | 0.09 | 19.14% |
| Q2 2022 Q2Q % growth | -0.56 43.43% | -0.83 | 0.27 | 32.22% |
| Q1 2022 Q2Q % growth | -0.84 4.55% | -1.01 | 0.17 | 16.82% |
| Q4 2021 Q2Q % growth | -0.09 90.91% | -1.01 | 0.92 | 91.09% |
| Q3 2021 Q2Q % growth | -0.88 20.00% | -0.84 | -0.04 | -4.58% |
| Q2 2021 Q2Q % growth | -0.99 | -0.90 | -0.09 | -10.29% |
| Q1 2021 Q2Q % growth | -0.88 33.33% | -1.01 | 0.13 | 12.85% |
| Q4 2020 Q2Q % growth | -0.99 18.18% | -0.95 | -0.04 | -3.81% |
| Q3 2020 Q2Q % growth | -1.10 16.67% | -1.12 | 0.02 | 1.96% |
| Q2 2020 Q2Q % growth | -0.99 50.00% | -1.57 | 0.58 | 36.97% |
| Q1 2020 Q2Q % growth | -1.32 20.00% | -1.38 | 0.06 | 4.61% |
| Q4 2019 Q2Q % growth | -1.21 | -1.38 | 0.17 | 12.56% |
| Q3 2019 Q2Q % growth | -1.32 | -1.80 | 0.48 | 26.47% |
| Q2 2019 Q2Q % growth | -1.98 | -1.88 | -0.10 | -5.36% |
| Q1 2019 Q2Q % growth | -1.65 | -2.02 | 0.37 | 18.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 16.071M -37.79% | 16.659M | -588K | -3.53% |
| Q1 2025 Q2Q % growth | 18.914M -16.59% | 17.809M | 1.105M | 6.20% |
| Q4 2024 Q2Q % growth | 24.665M 11.64% | 24.126M | 539K | 2.23% |
| Q3 2024 Q2Q % growth | 28.316M 19.12% | 27.028M | 1.288M | 4.77% |
| Q2 2024 Q2Q % growth | 25.832M 42.88% | 23.379M | 2.453M | 10.49% |
| Q1 2024 Q2Q % growth | 22.676M 15.29% | 22.138M | 538K | 2.43% |
| Q4 2023 Q2Q % growth | 22.093M 14.41% | 23.087M | -994K | -4.31% |
| Q3 2023 Q2Q % growth | 23.771M 27.19% | 23.302M | 469K | 2.01% |
| Q2 2023 Q2Q % growth | 18.08M -3.21% | 18.439M | -359K | -1.95% |
| Q1 2023 Q2Q % growth | 19.668M 22.01% | 19.499M | 169K | 0.87% |
| Q4 2022 Q2Q % growth | 19.31M 25.96% | 16.638M | 2.672M | 16.06% |
| Q3 2022 Q2Q % growth | 18.69M 16.89% | 19.757M | -1.067M | -5.40% |
| Q2 2022 Q2Q % growth | 18.68M 23.38% | 17.136M | 1.544M | 9.01% |
| Q1 2022 Q2Q % growth | 16.12M 4.20% | 19.176M | -3.056M | -15.94% |
| Q4 2021 Q2Q % growth | 15.33M 1.12% | 18.004M | -2.674M | -14.85% |
| Q3 2021 Q2Q % growth | 15.99M 4.65% | 18.542M | -2.552M | -13.76% |
| Q2 2021 Q2Q % growth | 15.14M -4.78% | 18.58M | -3.44M | -18.51% |
| Q1 2021 Q2Q % growth | 15.47M -2.46% | 17.729M | -2.259M | -12.74% |
| Q4 2020 Q2Q % growth | 15.16M -2.13% | 15.972M | -812K | -5.08% |
| Q3 2020 Q2Q % growth | 15.28M -0.84% | 15.986M | -706K | -4.42% |
| Q2 2020 Q2Q % growth | 15.9M 7.07% | 14.695M | 1.205M | 8.20% |
| Q1 2020 Q2Q % growth | 15.86M 1.93% | 16.118M | -258K | -1.60% |
| Q4 2019 Q2Q % growth | 15.49M | 16.549M | -1.059M | -6.40% |
| Q3 2019 Q2Q % growth | 15.41M | 16.338M | -928K | -5.68% |
| Q2 2019 Q2Q % growth | 14.85M | 16.724M | -1.874M | -11.21% |
| Q1 2019 Q2Q % growth | 15.56M | 17.238M | -1.678M | -9.73% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 18.18% | -350% | 14.63% | -6.06% |
| Revenue | 1.46% | -23.92% | 0.21% | 0.08% |